Report Categories
View AllRecent Articles
View All
Cherry Hill CHMI Stock SWOT Analysis Flirts with Support 20260415
CeriBell CBLL Future Plans CeriBell Inc beats EPS estimates by 144 on narrower loss
Virtu Financial VIRT Stock Detailed Breakdown At Highs 20260418
PSMT PriceSmart posts Q1 2026 earnings beat 72 percent year over year revenue growth lifts shares modestly
What Mega MGRT is doing that smart money tracks Modest Uptick 20260511
Is Fidus FDUS stock competitive Q4 2025 EPS Tops Views
FMNB Farmers stock climbs 161 percent even as Q4 2025 EPS lands 158 percent below analyst estimates
Oracle Gains More Analyst Confidence as Wedbush Lifts Price Target
From Proposal to Print The Economics Behind a Books Journey to Store Shelves
Paramotor Digital Technology Files Confidential IPO Draft Papers with SEBI
My Size MYSZ Q4 2025 Results Fall Short EPS 087 Revenue NA
Forrester Research FORR Q1 2026 Earnings Miss Sparks Concern
Tecogen TGEN Q1 2026 Earnings Beat Revenue NA EPS 007
Quantum Computing Stocks Rally as US Government Unveils 2 Billion Incentive Plan with Equity Stakes
Alaskas Oil Revival Sparks a New Energy Rush into the Arctic Region
Vanguard Warns Common Retirement Savings Mistake Could Cost Americans Up to 120000
SP 500 Edges Higher as Healthcare and Tech Strength Offset Utility Weakness
Democratic Strategist Warns DNC Election Autopsy Suggests Midterm Wins May Be by Default
Berkshire Hathaway Revamps Portfolio New Stakes in Delta Air Lines Alphabet Increase
Pasithea Therapeutics KTTA Q1 2026 Earnings NarrowerthanExpected Loss Drives Positive Market Reaction
OFS Credit Company Inc Q1 2026 Earnings Significant EPS Miss Amid Challenging Credit Environment
PLMR Q1 2026 Earnings EPS Surpasses Estimates by 301 Amid Modest Stock Pullback
CGBD Q1 2026 Earnings Narrow EPS Miss Weighs on Investor Sentiment as Portfolio Remains Resilient
Brixmor Property Group Q1 2026 Earnings Significant EPS Beat Driven by Operational Strength
EPAM Q1 2026 Earnings EPS Surpasses Estimates Amid Revenue Opacity
Douglas Dynamics PLOW Gains Ground Analyzing the Recent Uptick and Key Levels to Watch
FibroBiologics FBLG Edges Higher as Biotech Sector Shows Mixed Signals
Liminatus Pharma LIMN Holds Steady Near Resistance Consolidation Phase May Precede Directional Move
Protagonist Therapeutics PTGX Hovering Near Resistance After Modest Pullback
Skillsoft Corp SKIL Stages a Recovery Shares Jump 31 as Key Support Holds